Vancouver, BC -- (March 20, 2023) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC Markets: GBHPF / FRANKFURT: GHG) announces that Stephen D. Barnhill Jr. has been appointed interim President & CEO effective immediately. Curt Huber, former President & CEO will remain as a Director of the Company and will oversee GHG’s continuing industrial hemp related business segments.
Mr. Barnhill is currently the Chief Operating Officer (COO) of Apollon Formularies, plc, a natural biologics drug discovery company publicly traded on the Aquis Exchange in London, UK. As Apollon’s COO, he is responsible for all company operations in Jamaica, the Caribbean and North America. Stephen will be stepping down from that position immediately to become the Interim CEO of Global Hemp Group.
Stephen is the Co-Founder and President of Apollon Formularies, Inc. a US corporation established in 2014. He was instrumental in the international expansion of Apollon Formularies, Inc. to Jamaica in 2015, co-founding Apollon Formularies Jamaica, Ltd with headquarters in the Faculty of Medical Sciences at the University of the West Indies, Mona in Kingston. Apollon Formularies Jamaica, Ltd has a suite of vertical medical cannabis licenses from the Cannabis License Authority (CLA) including Cultivation Research and Development (allowing clinical trials), Processing, and Retail Therapeutic, an International Cancer and Chronic Pain Institute (ICCPI) in Kingston operating with a team of licensed medical doctors, Natural Psychedelic Therapeutics, Ltd to treat patients with psilocybin and an international medical tourism facility on the sea in Negril which treats international patients coming to Jamaica for treatment with Apollon’s natural biologic products.